LPAR1 and pancreatic neoplasm: Komachi et al. used oral administration of Ki16198 (specific inhibitors of LPAR1 and LPAR3) in nude mice modeled with pancreatic cancer cells, which inhibited tumor growth and reduced invasion and metastasis of other organs 83.